ClinicalTrials.gov
ClinicalTrials.gov Menu

Relation of Blood-boron Levels With Body Mass Index

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01400061
Recruitment Status : Unknown
Verified July 2011 by SB Istanbul Education and Research Hospital.
Recruitment status was:  Not yet recruiting
First Posted : July 22, 2011
Last Update Posted : July 22, 2011
Sponsor:
Information provided by:
SB Istanbul Education and Research Hospital

Brief Summary:
According to our experimental experiences w hypothesized that blood boron levels may be corralated to body mass index.

Condition or disease
Obesity

Detailed Description:
In the results of our experimental study on mices we revealed that low dose oral boric acid intake cause seriously body mas reducing. Although blood and urine analyses support high glucose, lipid and middle protein catabolisms, but the mechanism was unclear. There are some diseases according to blood elementary deficiencies, like hypothyroidi in hypoiyodinemia, hiperparathyroidi in hypocalcemia, etc. We hypothesised that hypoboronemia may be corralated to body mass index level.

Study Type : Observational
Estimated Enrollment : 80 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Phase 1 Study of Blood Boron Levels According to Body Mas Index
Study Start Date : August 2011
Estimated Primary Completion Date : October 2011
Estimated Study Completion Date : December 2011

Resource links provided by the National Library of Medicine

Drug Information available for: Boron
U.S. FDA Resources

Group/Cohort
normal
body mass index: 19-24
overweight
body mass index: 25-29
obesity
body mass index: 30-40
modbid obes
body mass index: over 40



Primary Outcome Measures :
  1. blood boron level [ Time Frame: 6 months ]
    blood boron levels will be measured cantitatively


Secondary Outcome Measures :
  1. body mass index [ Time Frame: 6 months ]
    body mass index levels will be evaluated with blood boron levels


Biospecimen Retention:   Samples Without DNA
blood serum analyses


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 45 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Normal: 19-24 Overweight: 25-29 Obes: 30-40 Morbid Obes: >40
Criteria

Inclusion Criteria:

  • body mas index levels in over 19 peoples

Exclusion Criteria:

  • known chronic, morbid and malign diseases

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01400061


Contacts
Contact: erhan aysan, assoc. prof. +902124531700
Contact: gokhan cipe, MD +902124531700

Locations
Turkey
Bezmialem Vakif University
Istanbul, Turkey, 34543
Sponsors and Collaborators
SB Istanbul Education and Research Hospital
Investigators
Study Chair: adnan yuksel, prof rector

Publications of Results:
Responsible Party: Bezmialem Vakif University, bezmialem vakif university
ClinicalTrials.gov Identifier: NCT01400061     History of Changes
Other Study ID Numbers: bor1
First Posted: July 22, 2011    Key Record Dates
Last Update Posted: July 22, 2011
Last Verified: July 2011

Keywords provided by SB Istanbul Education and Research Hospital:
obesity, etiology, pathogenesis, treatment